Publication:
The efficacy of n-acetylcysteine in preventing contrast-induced nephropathy in type 2 diabetic patients without nephropathy

Simple item page
dc.contributor.authorşar, Fuat
dc.contributor.authorSALER, Tayyibe
dc.contributor.authorECEBAY, Alphan
dc.contributor.authorSAGLAM, Zuhal A.
dc.contributor.authorOZTURK, Savas
dc.contributor.authorKazancioglu, RÜMEYZA
dc.contributor.institutionauthorKAZANCIOĞLU, RÜMEYZA
dc.date.accessioned2020-10-29T22:31:05Z
dc.date.available2020-10-29T22:31:05Z
dc.date.issued2010-07-01T00:00:00Z
dc.description.abstractBackground: N-acetylcysteine (NAC) is reported to have potential for prevention of contrast-induced nephropathy(CIN), however, there is not enough data related to its effects on diabetic patients without nephropathy.
dc.identifier.citationşar F., SALER T., ECEBAY A., SAGLAM Z. A. , OZTURK S., Kazancioglu R., -The efficacy of n-acetylcysteine in preventing contrast-induced nephropathy in type 2 diabetic patients without nephropathy-, JOURNAL OF NEPHROLOGY, cilt.23, ss.478-482, 2010
dc.identifier.scopus77955436635
dc.identifier.urihttp://hdl.handle.net/20.500.12645/26642
dc.identifier.wosWOS:000280225000016
dc.titleThe efficacy of n-acetylcysteine in preventing contrast-induced nephropathy in type 2 diabetic patients without nephropathy
dc.typeArticle
dspace.entity.typePublication
local.avesis.idb5e765a8-6454-4796-887f-37d09ab77999
local.indexed.atWOS
local.indexed.atScopus
local.publication.goal03 - Sağlık ve Kaliteli Yaşam
local.publication.isinternational1
relation.isAuthorOfPublicationeca7bd30-6b6e-444d-96ae-2961c39f2107
relation.isAuthorOfPublication.latestForDiscoveryeca7bd30-6b6e-444d-96ae-2961c39f2107
relation.isGoalOfPublication9c198c48-b603-4e2f-8366-04edcfc1224c
relation.isGoalOfPublication.latestForDiscovery9c198c48-b603-4e2f-8366-04edcfc1224c

Files

Collections

Diğer Yayınlar